Home  ›  CorDx  ›  CorDx TyFast Flu A/B & COVID-19 At Home Multiplex Rapid Test

CorDx TyFast Flu A/B & COVID-19 At Home Multiplex Rapid Test

Regular price $12.95
Sale price $12.95 Regular price $20.95
Unit price
Save 38%
In Stock
Rendering loop-subscriptions
Rapid, Comprehensive, Precise Results
  • Tests for Covid-19, Flu A, Flu B
  • Results in 10 minutes
  • Lower nasal swab
  • 1 test per box
  • Exp. Date: Jan 2026
Choose your purchase type:

Subscription Details:

  • Save 10-15% on all subscription orders!
  • Cancel anytime from your customer portal.
  • Super flexible subscription controls.
  • SMS/email notifications on upcoming orders.
  • Choose your delivery schedule:
Pickup available at PHARMALYNK WAREHOUSE

Usually ready in 4 hours

  • All orders ship the same day (Free $250+)

  • Save 10% — on auto-renew orders.

  • Wholesale Program available

The CorDx Tyfast Flu A/B & COVID-19 Multiplex Rapid Test is a lateral flow immunoassay intended for the in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS-CoV2, influenza A and influenza B directly from nasopharyngeal swab specimens obtained from individuals, who are suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider, within the first five days of onset of symptoms when tested at least twice over three days with at least 48 hours between tests. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high, or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

Transforming Global Diagnostics

CorDx manufactures point-of-care and over-the-counter rapid diagnostic products across a variety of categories, including infectious disease, reproductive & sexual health, substance abuse, and other health and marker tests. With authorization for use in the US (FDA), Europe (CE Mark) and China (NMPA), CorDx tests are known for their comfort, speed and accuracy. The flagship three-in-one test for Flu A/B & COVID-19 features a more comfortable synthetic nasal swab and provides reliable results in just 10 minutes.

FAQs

The test provides results within 10 minutes after sample application.

Yes, this test simultaneously detects Influenza A, Influenza B, and COVID-19 from one sample.

Yes, the test is suitable for individuals aged 2 years and older.

The test has high accuracy, with a Positive Percent Agreement of 89.6% for COVID-19, 85% for Flu A, and 87.5% for Flu B.

Store the test kits in a temperature range of 36°F - 86°F (2°C - 30°C).

About CorDx
A leader in IVD R&D, manufacturing, and supply chain.
CorDx is transforming the global diagnostics industry with innovative R&D solutions, a vertically integrated supply chain, and manufacturing footprints in the United States and around the world. With nearly two decades of IVD experience, CorDx is a leader in IVD research and development, manufacturing, and supply chain. Our proprietary line of rapid diagnostic products is recognized by families and medical professionals for reliability, affordability, and rapid results.
Shop all CorDx